Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$116,824,520
+$18,747,935 QoQ
Shares Held
7,356,708
+1.3% QoQ
Ownership
0.640%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Mar 31, 2024CallValue
$2,038,158
CallShares
170,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
This page
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in VTRS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,824,520 | 7,356,708 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $98,076,585 | 7,259,555 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $105,690,686 | 8,489,212 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $106,597,910 | 10,767,466 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $82,131,090 | 9,197,211 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,343,246 | 9,453,875 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $86,779,821 | 6,970,267 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $87,189,714 | 7,509,881 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $78,848,871 | 7,417,580 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,038,158 | 170,700 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $87,292,405 | 7,310,922 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $69,436,585 | 6,411,504 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $2,174,664 | 200,800 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $82,278,827 | 8,344,709 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $1,380,400 | 140,000 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $84,640,965 | 8,481,059 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $89,973,007 | 9,352,704 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $336,700 | 35,000 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $86,850,604 | 7,803,289 | Shares | Defined | 2023-02-10 | |
| 2022-12-31 | $723,450 | 65,000 | Call | Defined | 2023-02-10 | |
| 2022-09-30 | $70,325,779 | 8,254,200 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $90,781,021 | 8,670,585 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $125,482,180 | 11,533,289 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $148,927,981 | 11,007,242 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $160,455,085 | 11,841,704 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $175,745,561 | 12,298,500 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $8,507,730 | 609,000 | Call | Defined | 2021-05-14 | |
| 2021-03-31 | $166,980,570 | 11,952,797 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $183,717,117 | 9,803,475 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||